Entrepreneur and Aspen founder Stephen Saad feels vindicated in his quest to expand and build the sterile capacity that allows him to produce Johnson & Johnson’s vaccine on the African continent.

Saad told investors during the pharma group’s first-half results webinar that its Gqeberha (formerly Port Elizabeth) production facility was built with vaccines in mind. As a result, no adjustments to the manufacturing site have been necessary, in contrast with other plants abroad that have had to retool their facilities to make Covid-19 vaccines...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now